2017 Regular Session
|At the request of:|
|Chief Sponsors:||Senator Steiner Hayward, Representative Nosse|
|Bill Title:||Relating to the price of prescription drugs; declaring an emergency.|
Requires prescription drug manufacturer to report to Department of Consumer and Business Services prices and increases in prices of manufacturer's prescription drugs sold in Oregon.
Requires manufacturer to provide justification for increase in price greater than 3.4 percent for prescription drugs sold in Oregon longer than 36 months. Requires department to order manufacturer to refund excessive price increases to purchasers of prescription drugs. Declares emergency, effective on passage.
|Fiscal Impact:||May Have Fiscal Impact, But No Statement Yet Issued|
|Revenue Impact:||May Have Revenue Impact, But No Statement Yet Issued|
|Measure Analysis:||Staff Measure Summary / Impact Statements|
|Current Location:||In Senate Committee|
|Current Committee:||Senate Committee On Health Care|